日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ubiquitin ligase KLHL6 drives resistance to CD8(+) T cell dysfunction.

泛素连接酶 KLHL6 驱动对 CD8(+) T 细胞功能障碍的抵抗力。

Cheng Hongcheng, Su Yapeng, Pan Xiaoli, Xu Yue, Xie Ermei, Du Jing, Chen Daniel G, Dai Xiaomeng, Gottardo Raphael, Greenberg Philip D, Li Guideng

AGPAT3 reshapes tumor cell vulnerability to IFNγ-mediated ferroptosis and enhances immunotherapy efficacy through lipid remodeling.

AGPAT3 通过脂质重塑改变肿瘤细胞对 IFNγ 介导的铁死亡的敏感性,并增强免疫疗法的疗效。

Liu Chuan, Hu Chuan, Cheng Jinlin, Xin Duanfeng, Jin Sujie, Tian Weihong, Li Shan, Jin Yuzhi, Liu Yu, Wu Wei, Hao Shuqiang, Ren Hui, Dai Xiaomeng, Liu Lulu, Ruan Jian, Fang Weijia, Bao Xuanwen, Xin Shan, Zhao Peng

Nanodelivery of Traditional Chinese Medicine Monomers: An Emerging Strategy to Reprogram the Immunosuppressive Tumor Microenvironment

中药单体纳米递送:重塑免疫抑制性肿瘤微环境的新兴策略

Zhong, Lin; Xing, Minyan; Yu, Jiaze; Sun, Xuqi; Dai, Xiaomeng; Bao, Xuanwen; Huang, Chenping; Han, Jing; Li, Jianping; Zhao, Peng

Intra-arterial infusion of bevacizumab for the treatment of peritoneal metastatic high-grade renal cell carcinoma: a case report

动脉内输注贝伐单抗治疗腹膜转移性高级别肾细胞癌:病例报告

Jin, Song; Dai, Chaoming; Dai, Xiaomeng; Zhao, Peng; Zhou, Bin; Zhang, Jizhou; Fang, Weijia

Amplifying Anti-Tumor Immune Responses via Mitochondria-Targeting Near-Infrared Photodynamic Therapy

通过靶向线粒体的近红外光动力疗法增强抗肿瘤免疫反应

Li, Cheng-Ao; Nan, Junjie; Ye, Qingxuan; Zheng, Bingzhu; Dai, Xiaomeng; Li, Jingya; Wang, Feng; Ma, Huimin; Cheng, Yu; Ruan, Jian; Fang, Weijia; Zhao, Peng; Deng, Renren; Cen, Dong

Spatially resolved C1QC(+) macrophage-CD4(+) T cell niche in colorectal cancer microenvironment: implications for immunotherapy response.

结直肠癌微环境中空间分辨的 C1QC(+) 巨噬细胞-CD4(+) T 细胞微环境:对免疫治疗反应的影响

Zhang Hangyu, Hong Libing, Dong Zhen, Xin Shan, Lin Bo, Cheng Jinlin, Tian Weihong, Li Bin, Wang Jing, Liu Xiaoyan, Liu Chuan, Jin Yuzhi, Feng Yanzhi, Su Ge, Sun Xuqi, Liu Qiqi, Dai Xiaomeng, Gao Yang, Tong Zhou, Liu Lulu, Zhu Xudong, Zheng Yi, Zhao Peng, Guo Tiannan, Fang Weijia, Bao Xuanwen

Intraperitoneal infusion of NKG2D CAR-NK cells induces endogenous CD8(+) T cell activation in patients with advanced colorectal cancer.

腹腔内输注 NKG2D CAR-NK 细胞可诱导晚期结直肠癌患者体内内源性 CD8(+) T 细胞活化

Li Bin, Zhu Xudong, Ge Jingyu, Zhang Hangyu, Gao Yang, Bao Xuanwen, Dai Xiaomeng, Du Zhicheng, Tu Xiaoxuan, Tong Zhou, Fu Qihan, Hu Dongxue, Tian Weihong, Zheng Yi, Liu Lulu, Zhao Peng, Fang Weijia, Wang Shu, Wang Dongrui

Targeting inflammasomes as an immunotherapeutic strategy for cancer

以炎症小体为靶点的癌症免疫治疗策略

Huang, Luanluan; Chen, Xiaoyan; Liu, Ruiqi; Nan, Ding; Bao, Wenxuan; Yang, Lixian; Dai, Xiaomeng; Tang, Jianming; Zhang, Haibo; Lu, Yanwei

Lactylation in cancer: Advances and opportunities for treatment resistance

癌症中的泌乳作用:进展与治疗耐药性的机遇

Xu, Keke; Shou, Yiyi; Liu, Ruiqi; Xiong, Hao; Dai, Xiaomeng; Bao, Xuanwen; Chen, Xiaoyan; Huang, Luanluan; Sheng, Hailong; Zhang, Haibo; Lu, Yanwei

NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory study

NKG2D CAR-NK过继细胞免疫疗法联合或不联合PD-1阻断治疗转移性结直肠癌患者:一项探索性研究

Wang, Danyang; Li, Bin; Shen, Guojie; Zhang, Hangyu; Gao, Yang; Du, Zhicheng; Dai, Xiaomeng; Bao, Xuanwen; Zhu, Xudong; Tong, Zhou; Hu, Dongxue; Liu, Lulu; Zheng, Yi; Zhao, Peng; Wang, Shu; Fang, Weijia